No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Progesterone delivery device nets £1m funding from UK's NIHR
Research indicates that leaky progesterone pessaries used in threatened miscarriage cases cost the NHS £236m in avoidable costs yearly.
MHRA approves trofolastat for prostate cancer diagnostic imaging
Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion detection.
MHRA launches new monthly safety bulletins
Covering medical devices and medicines, the bulletins are part of the MHRA’s three-year strategy to improve safety communications.
UKHSA unveils high-risk pathogen list to drive innovation
The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.
EDX Medical develops new ‘super test’ for prostate cancer
According to EDX, the test studies the most comprehensive range of clinically validated prostate-related biomarkers currently known.
European supergroup launches to tackle diversity in clinical trials
The new pan-European group of 73 regulators, companies and trial sites is backed by €66.8m in funding with a six-year goal.
New report reveals ongoing industry challenges around EU’s IVDR and MDR compliance
MedTech Europe’s report reflects a lack of clarity over requirements, rising costs, and decreases in innovation activities.
‘Major milestone’ for UK clinical trials as new framework laid in parliament
The framework seeks to make the UK a desirable clinical trials location by expediting approvals and raising participant diversity.
Corti launches real-time AI clinical assistant
The foundation model underpinning Corti’s AI-based tool has been trained on over 250,000 patient interactions.
MHRA trials innovative AI technologies to consider regulatory approach
The MHRA is looking at five technologies in its AI Airlock pilot scheme, looking to inform its regulatory approach.
Telix Pharma doses first patient in Phase III PET carcinoma trial
Set to support a previous Phase III trial ahead of authorisation applications, the new Chinese trial is set to examine the systems use on clear cell renal cell carcinomas.
MHRA approves Eli Lilly’s Alzheimer’s diagnostic imaging agent Tauvid
Tauvid is to be used in PET scans to identify tau buildup to better diagnose Alzheimer’s disease.
MHRA calls for industry input on keeping EU law, IVD classification & more
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a consultation period calling on the public and private...
Medical Devices Development Services and Software Companies
Medical devices development services and software companies: Introduction In the complex and highly regulated world of medical device development, selecting...
MHRA puts technology in the spotlight in 2024/25 business plan
The MHRA’s 2024/25 business plan focuses on improving service delivery for its customers, enabling access to new technologies.
Qnovia set to trial smoking cessation inhaler in the US
The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in smokers.
Medical Device Consulting Services and Companies for the Medical Device Industry
The medical device industry is dominated by start-ups and small and medium-sized enterprises (SMBs) that are innovating rapidly. Furthermore, continued...
How are wearable patches revolutionising women’s health?
As the wearable tech industry is forecast to generate $290.6bn by 2030, patches are providing tailored healthcare needs to women.
Explainer: Labour has been elected in the UK – now what?
As Wes Streeting takes over the UK’s Department for Health and Social care, investors and industry bodies tentatively wait to see if the new Labour government will follow through on its promises.
New Labour government backs pharma reform in UK
As the UK transitions into a Labour government, the pharma industry urges for boosted investment and talent attraction.